Prolonged asymptomatic sinus pause indicated by implantable loop recording

Por Mairesse, G H, Marchand, B
Publicado em 2003

Questionnaire development: 4. Preparation for analysis.

Por Walop, W, Del Greco, L, Eastridge, L, Marchand, B, Szentveri, K
Publicado em 1987

Preparation of Biologically Active Single-Chain Variable Antibody Fragments that Target the HIV-1 gp120 V3 Loop

Por Ong, Y.T., Kirby, K.A., Hachiya, A., Chiang, L.A., Marchand, B., Yoshimura, K., Murakami, T., Singh, K., Matsushita, S., Sarafianos, S.G.
Publicado em 2012

THE SUGAR RING CONFORMATION OF 4’-ETHYNYL-2-FLUORO-2’-DEOXYADENOSINE AND ITS RECOGNITION BY THE POLYMERASE ACTIVE SITE OF HIV REVERSE TRANSCRIPTASE

Por Kirby, K.A., Singh, K., Michailidis, E., Marchand, B., Kodama, E.N., Ashida, N., Mitsuya, H., Parniak, M.A., Sarafianos, S.G.
Publicado em 2011

EFFECT OF TRANSLOCATION DEFECTIVE REVERSE TRANSCRIPTASE INHIBITORS ON THE ACTIVITY OF N348I, A CONNECTION SUBDOMAIN DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE MUTANT

Por MICHAILIDIS, E., SINGH, K., RYAN, E.M., HACHIYA, A., ONG, Y.T., KIRBY, K.A., MARCHAND, B., KODAMA, E.N., MITSUYA, H., PARNIAK, M.A., SARAFIANOS, S.G.
Publicado em 2012